文献速递淋巴瘤

早期T细胞前体淋巴母细胞淋巴瘤的基因组与临床特征

Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphoma.
PubMed 文献 · Blood Adv · 2021-01-01

该研究基于COG AALL0434临床试验中218例T淋巴母细胞淋巴瘤(T-LLy)患者的免疫分型数据,鉴定出9例(4%)具有明确早期T细胞前体(ETP)表型。对9例ETP-LLy和15例非ETP T-LLy进行SNP阵列分析,发现ETP-LLy具有独特的基因组特征,且4年无事件生存率达100%。

要点

  • ETP-LLy在T-LLy中占比4%,具有独特基因组特征。
  • ETP-LLy 4年无事件生存率100%,无治疗失败。
  • ETP-LLy的基因组改变不同于非ETP T-LLy及ETP-ALL。

核心结论

  • ETP-LLy未显示统一的遗传学改变,但具有区别于非ETP T-LLy的独特基因组特征,提示其可能为独立实体。

研究设计与样本

  • 回顾性分析COG AALL0434临床试验中218例T-LLy患者的免疫分型数据,鉴定出9例(4%)ETP-LLy。
  • 对9例ETP-LLy和15例非ETP T-LLy进行单核苷酸多态性(SNP)阵列分析。

主要发现

  • 与非ETP T-LLy相比,ETP-LLy的9p(CDKN2A/B)缺失频率更低,12p(ETV6)和1p(RPL22)缺失频率更高,双等位基因T细胞受体γ缺失更常见。
  • ETP-ALL中常见的5q、13q缺失和6q获得在ETP-LLy中未观察到。
  • ETP-LLy亚型无治疗失败,4年无事件生存率为100%。

临床怎么用

  • ETP-LLy患者可能预后良好,但需进一步验证以指导治疗策略。

局限性

  • 样本量小(ETP-LLy仅9例),结论需更大规模研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Early T-cell precursor phenotype acute lymphoblastic leukemia (ETP-ALL) is a subtype of T-ALL with a unique immunophenotype and genetic abnormalities distinct from conventional T-ALL. A subset of T lymphoblastic lymphoma (T-LLy) also demonstrates the early T-cell precursor immunophenotype and may be a counterpart of ETP-ALL. Unlike ETP-ALL, the incidence, clinical features, and genomic features of ETP-LLy are unknown. We reviewed the immunophenotyping data of 218 T-LLy patients who enrolled in the Children's Oncology Group AALL0434 clinical trial and identified 9 cases (4%) exhibiting a definitive ETP immunophenotype. We performed single-nucleotide polymorphism array profiling on 9 ETP-LLy and 15 non-ETP T-LLy cases. Compared with non-ETP T-LLy, ETP-LLy showed less frequent deletion of 9p (CKDN2A/B), more frequent deletion of 12p (ETV6) and 1p (RPL22), and more frequent absence of biallelic T-cell receptor γ deletions. Recurrent abnormalities previously described in ETP-ALL such as deletions of 5q and 13q and gain of 6q were not observed in ETP-LLy cases. There were no failures of therapy among the ETP-LLy subtype with a 4-year event-free survival of 100%. Overall, ETP-LLy does not exhibit unifying genetic alterations but shows some distinct genomic features from non-ETP T-LLy suggesting that ETP-LLy may be a distinct entity from non-ETP T-LLy.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Xu X, Paxton CN, Hayashi RJ, et al. Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphoma. Blood Adv. 2021. PMID: 34297047. doi:10.1182/bloodadvances.2021004334

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。